In situ carcinoma
MONDO:0004647A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.
Also known as: CIS, carcinoma in situ, carcinoma, in situ, malignant, epithelial tumor, in situ, malignant, intraepithelial carcinoma, non-invasive carcinoma, stage 0 disease
3066 clinical trials for this condition and its sub-types, 25 tagged with In situ carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of In situ carcinoma
-
Breast carcinoma in situ 76 trials · 204 incl. sub-types
4 sub-types
- Ductal breast carcinoma in situ 152 trials Sub-types →
- Lobular neoplasia 4 trials · 30 incl. sub-types Sub-types →
- Ductal breast carcinoma in situ and lobular carcinoma in situ 1 trial
- Breast apocrine carcinoma in situ 0 trials
-
Adenocarcinoma in situ 10 trials · 170 incl. sub-types
3 sub-types
- Ductal breast carcinoma in situ 152 trials Sub-types →
- Lobular breast carcinoma in situ 27 trials
- Lung adenocarcinoma in situ 1 trial
-
Bladder carcinoma in situ 30 trials
-
Intestine carcinoma in situ 0 trials · 16 incl. sub-types
2 sub-types
- Rectum carcinoma in situ 1 trial · 13 incl. sub-types Sub-types →
- Colon carcinoma in situ 3 trials Sub-types →
-
Uterus carcinoma in situ 0 trials · 16 incl. sub-types
2 sub-types
- Uterine cervix carcinoma in situ 15 trials
- Endometrium carcinoma in situ 1 trial
-
Esophagus carcinoma in situ 13 trials
-
Squamous carcinoma in situ 5 trials · 10 incl. sub-types
3 sub-types
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
- Penis carcinoma in situ 1 trial
- Trachea carcinoma in situ 0 trials
-
Skin carcinoma in situ 3 trials · 9 incl. sub-types
1 sub-type
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
-
Oral cavity carcinoma in situ 5 trials
1 sub-type
- Lip carcinoma in situ 0 trials
-
Stomach carcinoma in situ 4 trials
3 sub-types
- Carcinoma in situ of fundus of stomach 0 trials
- Carcinoma in situ of gastric body 0 trials
- Carcinoma in situ of gastric cardia 0 trials
-
Lung carcinoma in situ 2 trials · 3 incl. sub-types
2 sub-types
- Lung adenocarcinoma in situ 1 trial
- Bronchus carcinoma in situ 0 trials
-
Pharynx carcinoma in situ 0 trials · 2 incl. sub-types
3 sub-types
-
Larynx carcinoma in situ 1 trial
1 sub-type
- Carcinoma in situ of epiglottis 0 trials
-
Carcinoma in situ of ureter 0 trials
-
Carcinoma in situ of urethra 0 trials
-
Eye carcinoma in situ 0 trials
-
Gall bladder carcinoma in situ 0 trials
-
Kidney carcinoma in situ 0 trials
1 sub-type
- Carcinoma in situ of renal pelvis 0 trials
-
Liver carcinoma in situ 0 trials
1 sub-type
- Bile duct carcinoma in situ 0 trials Sub-types →
-
Nasal cavity carcinoma in situ 0 trials
Most studied deeper sub-types
-
Light-Activated therapy could offer Surgery-Free route for early anal cancer
Disease control CancelledThis early-phase trial is testing whether a light-activated treatment, called photodynamic therapy (PDT), combined with vitamin D3, can safely treat high-grade anal dysplasia and very early anal cancer. Participants receive a photosensitizing drug that makes abnormal cells sensit…
Phase 1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Virus therapy shows promise for tough bladder cancer cases
Disease control OngoingThis phase 3 trial is testing a new treatment called cretostimogene grenadenorepvec for people with a type of bladder cancer (non-muscle invasive) that did not improve after standard BCG therapy. The treatment uses a modified virus to target and destroy cancer cells. About 190 pa…
Phase 3 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC